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ABSTRACT
Like alternative splicing, leaky ribosomal scanning
(LRS), which occurs at suboptimal translational initi-
ation codons, increases the physiological flexibility
of the genome by allowing alternative translation.
Comprehensive analysis of 22 208 human mRNAs
indicates that, although the most important positions
relative to the first nucleotide of the initiation codon,
3 and 14, are usually such that support initiation
(A3 = 42%, G3 = 36% and G14 = 47%), only 37.4%
of the genes adhere to the purine (R)3/G14 rule at
both positions simultaneously, suggesting that LRS
may occur in some of the remaining (62.6%) genes.
Moreover, 12.5% of the genes lack both R3 and G14,
potentially leading to sLRS. Compared with 11 genes
known to undergo LRS, 10 genes with experimental
evidence for high fidelity A11T12G13 initiation codons
adhered much more strongly to the R3/G14 rule.
Among the intron-less histone genes, only the H3
genes adhere to the R3/G14 rule, while the H1,
H2A, H2B and H4 genes usually lack either R3 or
G14. To address in vivo the significance of the pre-
viously described LRS of H4 mRNAs, which results
in alternative translation of the osteogenic growth
peptide, transgenic mice were engineered that
ubiquitously and constitutively express a mutant
H4 mRNA with an A11!T11 mutation. These trans-
genic mice, in particular the females, have a high
bone mass phenotype, attributable to increased
bone formation. These data suggest that many
genes may fulfill cryptic functions by LRS.
INTRODUCTION
The fewer than expected protein-coding sequences in
mammalian genomes (1,2) underscore the importance of gene
multi-functionality. The most commonly described mechan-
ism of obtaining several proteins from a single gene is alter-
native splicing, whereby various mRNAs are derived from the
same nascent transcript. Deriving diverse proteins from a
single mature transcript via alternative translation is emerging
as an additional mechanism by which cells utilize a single gene
to fulfill multiple functions (3). One type of alternative trans-
lation occurs in a cap-independent manner through internal
ribosomal entry sites (4). This mechanism was initially
described in viral genomes and later in a growing number
of cellular mRNAs (4). A second type of alternative transla-
tion is mediated by leaky ribosomal scanning (LRS) and is
cap-dependent (3). In these cases, the optimal sequence
(50-CCRCCAUGG-30) surrounding the first AUG initiator is
compromised, leading to LRS and translational initiation at
both the imperfect (but first, hence most accessible) AUG and
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additional, downstream, AUG(s). Infrequent AUG initiators
that are boldly different from the consensus are inefficient
and allow strong leaky ribosomal scanning. Such is the
case when both of the most important consensus nucleotides,
R3 and G+4, are concomitantly absent (5,6).
sLRS caused by poor AUG initiators, frequently found in
mRNAs encoding regulatory proteins (7), can be expected to
result in the accumulation of alternative translation products to
levels comparable with those of the protein translated from
the first AUG. Weak LRS, which presumably goes unnoticed
in many mammalian mRNAs, would result in significant
accumulation of an alternative translation product when the
mRNA in question is relatively abundant and the alternative
translation product relatively stable. Such is the case for
histone H4 mRNA. The good, but imperfect H4 first AUG
initiation codon allows significant LRS that supports the
alternative translation of the osteogenic growth peptide
(OGP) from a second, downstream AUG initiator, which is
surrounded by an optimal sequence (17). Thus, histone H4
genes, among the most ancient in eukaryotes, lack introns
but encode at least two functionally diverse peptides by a
mechanism of LRS: (i) the 103 amino acid histone H4 protein,
which participates in DNA packaging and in transcriptional
regulation through post-translational modifications of its
N-terminal tail (9), and (ii) OGP, a circulating peptide ident-
ical to the C-terminus of histone H4, which participates in the
regulation of bone formation and hematopoesis (8,10).
In the present paper, we provide a genome-wide estimate of
the frequency of genes potentially undergoing LRS due to lack
of R3 and/or G+4. To demonstrate the significance of LRS
in vivo, we assessed the outcome of histone H4 alternative
translation by generating transgenic mice that express a mutant
histone H4 mRNA, H4tTG1, which can produce OGP but not
histone H4 protein. Transgenic mice, in particular females,
have elevated trabecular bone formation, resulting in increased
bone mass and improved structural integrity of the trabecular
network. These results portray the diverse functionality of
histone H4 alternative translation products and highlight the
potential biological significance of LRS, a mechanism that
likely gives rise to hundreds of yet unstudied peptides.
MATERIALS AND METHODS
Computational methods
Human mRNA sequences were downloaded from the NCBI
ftp website (ftp://ftp.ncbi.nih.gov/genomes/H_sapiens/RNA/),
which contains 27 330 mRNA sequences (refseq). Of these,
22 208 files that contained 50 untranslated region (5-UTR)
sequences were used for analysis. Human and mouse histone
mRNA sequences (refseq) were downloaded from the
GenBank database for each species using histone[TITL] as
keyword, and are listed in Supplementary Table S1. To
demonstrate sequence conservation around initiation codons,
Plot Sequence Logo diagrams were generated as described
previously (11–13).
Functional categorization of genes with predicted sLRS was
accomplished using the Onto-Tools database suite (14,15)
(http://vortex.cs.wayne.edu/Projects.html). First, a master list
of 2290 sLRS genes that each correspond to a single unigene
cluster was generated using the Onto-Translate application in
the Onto-Tools database suite (14,15) and Microsoft Excel to
remove repeats. Second, a reference list of 19 494 human
mRNA sequences with unique unigene cluster assignments
was generated using the same strategy. The Onto-Compare
data mining tool in Onto-Tools was then employed to identify
function categories defined by the Gene Ontology (GO) Con-
sortium that are over-represented in the sLRS gene group.
Over-representation was examined for statistical significance
using the binomial distribution setting with the FDR correction
factor.
Transgene construction
For over-expression of the H4 alternative translation product,
we used the entire H4 coding sequence, excluding the
30-UTR, of the X13554 rat H4 gene (16), in which we mutated
the ATG initiation codon to tTG. This choice was based
on the recurrent observation that the H4–CAT fusion gene
pSVrH4D87–103CAT(T/A) expressed at higher levels compared
with the CAT gene in the absence of H4 sequences (17), sug-
gesting that histone H4 mRNA elements may contribute to
message stability. The ATG-to-tTG mutation was introduced
by PCR-amplification of the X13554 rat H4 gene with the
forward primer 50-TCTTCTgGaTCCATTACTGCTCTACT-
AGGAAGtTGTCTGG-30, where the italicized t represents the
mutation in the initiation codon and the other letters in lower-
case represent substitutions that generate a BamHI restriction
site (underlined). The reverse primer was 50-CAAGGAGAA-
ttCCTAGACAAACG-30, where letters in lowercase represent
substitutions that generate an EcoRI restriction site (under-
lined). The PCR product was digested with BamHI and EcoRI
and inserted by blunt end ligation into the XhoI site of pCAGGS
(18), between the chicken b-actin promoter plus intron and the
rabbit b-globin 30-UTR (Figure 4A). This strategy restored the
XhoI site at the H4/b-globin junction. The resultant construct,
named H4tTG1, also contains the cytomegalovirus enhancer
from pCAGGS (Figure 4A). The transgene was separated from
vector sequences by digestion with SalI and HindIII and iso-
lated using a gel purification kit (Qiagen, Inc.).
Animals
Transgenic mice were generated in the transgenic core facility
of the University of Southern California. Transgenesis and
breeding were performed with a first generation cross of
C57Black/6 and DBA2 mice from The Jackson Laboratory.
Transgenic mice were identified using tail DNA based on
the presence of the rabbit b-globin 30-UTR, either by Southern
blot analysis or by PCR. Distribution of the H4tTG1 transgene
followed a Mendelian inheritance pattern. Wild-type and het-
erozygous transgenic females and males were examined at 8,
17 and 34 weeks of age, 5–12 mice per gender/age/genotype
group. To study bone formation, newly formed bone was vitally
labeled by the fluorochrome calcein (Sigma) injected intraperi-
toneally (15 mg/kg) 4 days and 1 day prior to sacrifice. At sac-
rifice, the femora were dissected, fixed in phosphate-buffered
formalin for 48 h and further kept in 70% ethanol. Soft tissues
for northern analysis were snap-frozen in liquid nitrogen.
Northern blot analysis
Transgene expression was analyzed in selected tissues by
northern blot analysis. The tissues were homogenized in
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Trizol1 solution (Invitrogen Corp., Carlsbad, CA) followed
by chloroform extraction and precipitation in isopropanol. The
probe was a 0.5 kb XhoI–PstI fragment of pCAGGS, contain-
ing the rabbit b-globin 30-UTR. For endogenous H4 gene
expression, the probe was a 0.3 kb cDNA fragment containing
the entire murine ‘clone 12’ H4 coding sequence (accession
no. X13235) (19).
Micro-computed tomographic (mCT) analysis
Whole femora were examined by a mCT system (mCT 40;
Scanco Medical AG, Basserdorf, Switzerland) equipped
with a 5 mm focal spot microfocus X-ray tube as a source.
A 2D CCD, coupled to a thin scintillator as a detector per-
mitted parallel acquisition of stacks including 20 tomographic
images. The long axis of the femur was set parallel to the plane
of the X-ray beam axis. The X-ray tube was operated at
50 KVp and 160 mA. The integration time was set to 100 ms.
The scans were performed at a resolution of 20 mm in all three
spatial dimensions (medium resolution mode). The 2D CT
images were reconstructed in 1024 · 1024 pixel matrices
from 1000 projections using a standard convolution–
backprojection procedure with a Shepp and Logan filter.
Images were stored in 3D arrays with an isotropic voxel
size of 20 mm. A constrained 3D Gaussian filter (width:
s = 0.8, support: one voxel width) was used to partly suppress
the noise in the volumes. The samples were binarized using a
global thresholding procedure (20). The threshold was set to
22.4 and 16.0% of the maximal gray scale value for cortical
bone and trabecular bone, respectively. Morphometric para-
meters were determined using a direct 3D approach (21) in (i)
secondary spongiosa in the distal metaphysis; and (ii) cortical
bone in a 1 mm thick segment in the mid-diaphysis. The
overall femoral length was also measured.
Histomorphometry
After mCT image acquisition, the specimens were dehydrated
in progressive concentrations of ethanol, cleared in xylene
and embedded undecalcified in polymethylmethacrylate
(Technovit 9100; Heraeus Kulzer, Wehrheim, Germany).
Undeplasticized, longitudinal 5 mm sections were left
unstained for fluorescent microscopy and dynamic histo-
morphometric measurements based on the calcein double
labeling. To identify osteoclasts, consecutive sections were
deplasticized and stained for tartrate-resistant acid phos-
phatase [TRAP; (22)] using an acid phosphatase kit (Sigma,
St Louis, MO) and counterstained with Mayer’s hematoxylin.
Histomorphometric analysis was carried out on digital photo-
micrographic images using Image-Pro Express Version 4.0.1
image analysis software (Media Cybernetics, Silver Spring,
MD). The measurements, terminology and units used for the
histomorphometric analysis were according to the convention
of standardized nomenclature (23).
Statistical analysis
All analyses were carried out using SigmaStat software (SPSS
Science, Chicago, IL). The significance of differences in quan-
titative mCT and histomorphometric studies was determined
based on the analysis of variance (ANOVA). When significant
differences were indicated by ANOVA, group means were
compared using the Tukey test.
RESULTS
Nucleotides flanking ATG initiation codons:
whole genome overview
We screened 22 208 human mRNA files available on the NCBI
webpage that contain 50-UTR sequences for nucleotides that
occupy positions from 10 to +10 relative to the first nucle-
otide of the annotated translation initiation codon. As shown in
Figure 1, several of these positions (in addition to A+1, T+2 and
G+3) exhibit various degrees of conservation. The most con-
served position is 3, with A and G present in 42 and 36%
of the mRNAs, respectively. Position +4 exhibited a strong
A
B
Figure 1. Analysis of nucleotides flanking the initiation codons of human
genes. (A) Preferred occupancy of positions around the initiation codons of
22 208 human mRNAs was evaluated and diagrammatically illustrated on a Plot
Sequence Logo as described previously (11–13). Nucleotides found more
frequently than others are indicated, with the size of the corresponding
letter reflecting their frequency. Positions with no illustration indicate close-
to-equal distribution of all 4 nt. (B) Occupancy of positions3 and +4 in 22 208
human mRNAs. The left column and the top row indicate the fraction of genes
with the indicated nucleotides at positions3 and+4, respectively. The internal
cells represent the 16 possible3/+4 combinations. Nucleotide frequencies are
depicted numerically and illustrated by triangles of corresponding sizes.
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predilection for G (47%). Of the 16 possible 3/+4 nucleotide
pairs, A3/G+4 and G3/G+4 are found most frequently, each
approaching 19%, while the least frequent pairs are those
without G+4 and without A3 or G3 (Figure 1B). Each of
these six rare pairs (C3/A+4, C3/C+4, C3/T+4, T3/A+4,
T3/C+4 and T3/T+4) is found in 1.6–2.8% of the entire
mRNA population, totaling 12.5% (Figure 1B). These trends
are consistent with the known contribution of nucleotides at
positions 3 and +4 to ribosomal recognition of initiation
sites, because a purine at position 3 and a G at position +4
best support translational initiation (5,6). However, the results
also highlight a large number of start codons with suboptimal
and even unfavorable sequence context for translational
initiation.
Nucleotides flanking ATG initiation codons of
genes known to undergo LRS
mRNAs with suboptimal initiation codons undergo LRS,
which can result in translational initiation at alternative, down-
stream AUGs [reviewed in (3)]. Although the small number of
genes with experimental evidence for LRS does not allow a
thorough investigation of nucleotide frequency at positions
flanking the first initiation codon of such genes, Figure 2A
shows for a small number of such genes that they do not seem
to follow the overall R3 and G+4 genome-wide trends. In fact,
only 4 of the 11 genes in the LRS group (Table 1) have a purine
at 3 and only 2 have a G at +4. None of the 11 genes has the
R3/G+4 combination. In contrast, each of the 10 genes ran-
domly picked from the published literature, for which evid-
ence exists for lack of LRS, has a purine at position 3, and 4
of them have a G at position +4 (Table 2 and Figure 2B).
To test whether poor first translational initiation codons
are preferentially found in genes with a particular function(s),
we interrogated the genes with the predicted strongest LRS
(sLRS gene group), i.e. those without R3 and without G+4,
for characteristic functions based on the GO Consortium
annotations (24). We compared the frequency of each GO
designation within this group of genes with the respective
frequency within the entire gene pool from which it was
derived. We did not find in the sLRS gene group any GO
category that was over-represented with a corrected P-value
<0.05. Thus, poor first AUG initiation codons do not appear to
preferentially associate with any particular gene function.
Nucleotides flanking ATG initiation codons of
human and mouse histone genes
We have previously shown that histone H4 mRNAs, which
lack the favorite G at position +4, undergo LRS, giving rise
Figure 2. Analysis of nucleotides flanking the initiation codons of human genes known to undergo or not undergo LRS. Preferred nucleotides at
the 10/+10 positions is depicted as in Figure 1A. Occupancy of the 3 and +4 positions is depicted as in Figure 1B. (A) LRS group (see Table 1).
(B). Non-LRS group (see Table 2).
Table 1. mRNAs known to undergo LRSa
Gene name Accession no. Sequence flanking first ATG (10/+10) References
Glucocorticoid receptor NM_000176 ATATTCACTGATGGACTCCA (39)
NFAT NM_172390 CGCCGCGCGGATGCCAAGCA (40)
GATA-1 NM_002049 CAGAGGCTCCATGGAGTTCC (41)
MxB M30818 GAGACAGCACATGTCTAAGG (42)
Ubiquitin-activating enzyme E1 BC013041 GGCACAGGGGATGTCCAGCT (43)
Microtubule-associated protein BC007318 GAGTGCGCCAATGCCTGGGC (44)
Von Hippel–Lindau gene NM_000551 CGCGGAGGGAATGCCCCGGA (45)
p70 S6 kinase M60724 GTCCGGGCCCATGAGGCGAC (46)
Folylpolyglutamate synthase BC064393 CGCCGGGACTATGTCGCGGG (47)
T-cell receptor gamma chain AF151103 AAACAACTTGATGCAGATGT (48)
Embryonic ectoderm development (EED) NM_003797 GCGGAGGAATATGTCCGAGA (49)
aSelected based on (3) and manual literature search of PubMed.
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to OGP (17). Because histone genes lack introns, LRS is
probably the main mechanism by which they might give
rise to diverse products. We therefore screened the sequences
flanking the AUG initiation codons of all human histone
mRNAs available in the GenBank database (Supplementary
Table S1). As shown in Figure 3A and B, most of human
histone mRNAs do not have the R3/G+4 combination, and
are therefore candidates for LRS. With the exception of his-
tone H3 mRNA, the nucleotide at position +4 is usually a T
(for histones H1, H2A and H4) or a C (for histone H2B). These
same ‘unpopular’ trends are conserved in mouse histone genes
(Figure 3C and D). However, no human histone gene and only
four mouse genes (from a total of 77, highlighted in Supple-
mentary Table 1) lack both an R3 and a G+4 (Figure 3).
Potential LRS-mediated alternative translation
products of human and mouse histone genes
We next examined every human and every mouse histone gene
that lacks either R3 or G+4 for the presence of an alternative
open reading frame(s) [ORF(s)], which, following LRS, could
give rise to an alternative peptide of 16 or more amino acids.
We found such alternative ORFs in every histone gene family
in both human and mouse (Supplementary Table 2). Many of
the alternative ORFs are in-frame, starting at an internal
methionine codon. However, approximately half the alternat-
ive ORFs found within the human H1, H2A and H2B families
are out of frame, and several of them have similar homologs
in the mouse. These are predicted to give rise to a 33 amino
acid peptide encoded by nucleotides 206–304 of HIST1H2AB,
a 26 amino acid peptide encoded by nucleotides 197–274
of H2AFY and a 21 amino acid peptide encoded by nucle-
otides 77–139 of each of HIST1H2BB and HIST1H2BM
(Supplementary Table 2). Such peptides are prime candidates
for future investigation of cryptic peptides encoded by histone
genes, which may be highly expressed in proliferating cells and
could fulfill functions very different from DNA packaging.
H4tTG1 transgenic mice
The above bioinformatic analysis highlights the potential for
synthesis of a plethora of cryptic peptides by a mechanism of
LRS. We have previously demonstrated that LRS accounts for
the translation of OGP from histone H4 mRNA (17). To
address the significance of histone H4 LRS in vivo, transgenic
mice were generated that carry the H4tTG1 transgene
described in Figure 4A. H4tTG1 encodes OGP but not histone
H4, due to a mutation substituting the A+1T+2G+3 H4 initiation
codon for t+1T+2G+3. The transgene regulatory sequences were
designed to promote ubiquitous (b-actin promoter) high-level
[cytomegalovirus (CMV) enhancer] expression. In addition,
the H4tTG1 mRNA was designed to be equally stable in pro-
liferating and quiescent cells, by replacing the histone H4
30-UTR, which is responsible for cell cycle-dependent tran-
script stability (25), with the rabbit b-globin 30-UTR. Results
presented here are from one of the two independent transgenic
lines, which had a similar expression pattern and a similar
phenotype. Figure 4B presents northern blot analysis of the
H4tTG1 transgene next to endogenous histone H4 in muscle
and spleen of a transgenic mouse. The results show that the
H4tTG1 transgene is expressed in muscle on a minimal back-
ground of endogenous histone H4 expression, reflecting the
post-mitotic state of most muscle cells and the independence
of H4tTG1 expression on proliferation. Expression of the
H4tTG1 transgene was much lower in spleen than in muscle
(Figure 4B), with liver, brain and kidney displaying interme-
diate levels (Figure 4C). Expression in bone was high, similar
to that seen in muscle, and, important for the interpretation of
data presented below, no significant difference was observed
between females and males (Figure 4D).
High bone mass (HBM) phenotype
in H4tTG1 transgenic mice
The H4tTG1 transgenic mice displayed no overt phenotype at
birth and followed normal growth curves (data not shown).
Several transgenic mice maintained up to the age of 18 months
were grossly indistinguishable from littermate controls.
Because OGP has been implicated in osteoblast differentiation
and bone formation (10), we compared femora from trans-
genic and control mice. mCT analysis performed at 8, 17
and 34 weeks of age showed that the H4tTG1 transgene
induced a HBM phenotype, and that this phenotype was
much more pronounced in females than in males (Figure 5).
In H4tTG1 transgenic females of all three ages, the mCT
analysis showed an 2-fold higher trabecular bone volume
density (BV/TV) as compared with controls (Figure 5A). The
higher BV/TV was attributable mainly to increased trabecular
number (Tb.N; Figure 5B), while the differences in trabeculcar
Table 2. mRNAs that do not undergo LRSa
Gene name Accession no. Sequence flanking first ATG (10/+10) References
HDAC6 NM_006044 CTCCTCAACTATGACCTCAA (50)
HDAC5 AF132608 CAGAGCCGGCATGAACTCTC (50)
HDAC4 NM_006037 ATTGCTAGCAATGAGCTCCC (50)
UDP-glucuronosyl transferase AJ005162 TTGCATCAGGATGTCTATGA (51)
Cannabinoid receptor 1 NM_016083 GACTGAGGTTATGAAGTCGA (52)
C1-tetrahydrofolate synthase AY374130 GTCCCGCGCCATGGGCACGC (53)
Cytokine inducible nuclear protein X83703 GTCCCGCGCCATGGGCACGC (54)
Nephrin (NPHS1) AF035835 GGGACCTGTGATGGCCCTGG (55)
ALK4 (activin A receptor, type IB) NM_004302 GGTGGTTACTATGGCGGAGT (56)
ASK1 D84476 GCCCGGAGAGATGAGCACGG (57)
aSelected based on published western blots. Approximately 100 genes, for which published western analyses showed a single band, were examined. Of these,
the 10 genes depicted in the Table had an in-frame internal AUG codon, which could have resulted in a second protein product, detectable by the antibody
used, if LRS had occurred at the first AUG.
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thickness (Tb.Th) were small and statistically insignificant
(Figure 5C). The connectivity density (Conn.D), a measure
of the number of trabecular connections that can be broken
before the structure collapses (26), was also markedly
increased in female transgenic mice (Figure 5D). The
computed differences between the H4tTG1 transgenic and
wild-type females are evident in 3D reconstituted femoral
metaphyseal images that show a substantially denser, intern-
ally more connected structure compared with a representative
control image (Figure 5I and J). In males, a significant albeit
smaller increase in trabecular bone volume density was
observed only in the 34-week age group (Figure 5E). Notably,
all the structural changes were restricted to trabecular bone;
cortical bone parameters, as well as the overall femoral dimen-
sions, had similar values in transgenic and wild-type mice
(Supplementary Tables S3 and S4).
Increased bone formation in H4tTG1
transgenic mice
Parameters of bone formation and bone resorption were
compared between H4tTG1 transgenic and control mice at
Figure 3. Analysis of nucleotides flanking the initiation codons of histone genes. (A and C) Preferred nucleotides at the10/+10 positions is depicted as in Figure 1A.
(B and D) Occupancy frequency at the 3 and +4 positions, as well as the frequency of each 3/+4 combination, are depicted as in Figure 1B. (A and B), human
histone genes (9 H1, 30 H2A, 19 H2B, 14 H3 and 14 H4 genes); (C and D), mouse histone genes (9 H1, 23 H2A, 17 H2B, 15 H3 and 13 H4). Gene list is provided in
Supplementary Table S1.
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the ages of 8 and 17 weeks. Bone formation was evaluated
based on calcein double labeling of actively forming bone
surfaces (23). Osteoclast number, a surrogate for bone resorp-
tion, was determined based on staining for TRAP (22).
The H4tTG1 transgenic mice exhibited significantly higher
values of bone formation parameters, and consistent with
the HBM phenotype, these effects were observed in females
(Figure 6A–C) but not in males (Figure 6D–F). Specifically,
H4tTG1 females exhibited a 32–42% higher mineralizing
perimeter (Min.Peri), i.e. the percentage of trabecular surfaces
engaged in bone formation (Figure 6A) and thus a surrogate
for the number of osteoblasts. The increase in the Min.Peri is
illustrated by the extensive calcein labeling of bone surfaces
in a trabecular bone section from a representative H4tTG1
female (Figure 6H) as compared with a non-transgenic control
(Figure 6G). In addition, the H4tTG1 females showed a 23–
39% increase in the mineral appositional rate (MAR), meas-
ured as the distance between the two lines at doubly labeled
surfaces (Figure 6B, G and H), which represents the activity of
osteoblasts. The overall bone formation rate (BFR), the
numerical product of the Min.Per and MAR, was60% higher
in the H4tTG1 transgenic females of both age groups as
compared with their age-matched controls (Figure 6C). No
significant differences were observed in the osteoclast number
per trabecular surface area between the H4tTG1 transgenic and
control mice (Table 3). Thus, the HBM phenotype is attrib-
utable to a net bone anabolic effect of the H4tTG1 transgene
product(s).
DISCUSSION
We scanned most human genes for nucleotides occupying
the positions that flank their annotated initiation codons.
The preferences for the respective purine and guanine residues
at positions 3 and +4 are consistent with results reported
previously for a smaller dataset (7). The R3/G+4 combina-
tion has been shown to confer high fidelity on an AUG as a
translational initiator (5,6). In addition, our analysis indicates a
preference, albeit to a lesser degree, for a C at position 1,
which also contributes to the fidelity of translational initiation
(5). Finally, we observe a secondary preference for A at posi-
tion +4. The functional significance of this observation
remains to be examined.
Only 37.4% of human mRNAs have both R at position 3
and G at position +4, and can thus be expected to be translated
starting exclusively at the annotated AUG initiator. A signi-
ficant fraction of the mRNAs, 12.5%, which have neither an
R3 nor a G+4, can be expected to experience relatively strong
LRS, potentially yielding significant concentrations of
alternatively translated, biologically significant products.
The remaining 50% of human genes, without an R3 or with-
out a G+4, but with the preferred nucleotide at the other key
position, may undergo weaker LRS, although its frequency,
magnitude and biological significance remain to be examined.
In some of these cases, alternatively translated peptides would
accumulate to biologically significant levels in cases of abund-
ant mRNAs. Such may be the case for the ancient histone
mRNAs, which accumulate to high levels in proliferating
cells, inasmuch as most of them, with the exception of H3,
usually lack either R3 or G+4 (Figure 3). While productive
alternative translation has been experimentally demonstrated
only for histone H4 mRNA (17), sequence analysis suggests
that a similar mechanism likely gives rise to cryptic peptides
encoded by additional histone genes (Supplementary Table 2).
The potential biological significance of LRS is demon-
strated in the present paper by over-expression of a histone
H4 alternative translation product. The increased bone mass
observed in the H4tTG1 transgenic mice cannot be ascribed to
the full-length H4 gene product, or to histone H4-derived
proteolytic products, because the H4tTG1 transgene lacks
the first AUG codon that initiates histone H4 translation.
Instead, the HBM phenotype is most likely mediated by
OGP or a related histone H4 alternative translational pro-
duct(s). Unfortunately, loss-of-function approaches to study
the physiological significance of H4 alternative translation are
Figure 4. (A) Schematic illustration of the H4tTG1 transgene. The transgene is composed of the human CMV enhancer, the chickenb-actin promoter and intron, a rat
histone H4 coding sequence and the rabbit b-globin 30-UTR. Within the H4 box, t represents the mutation in the H4 translational initiator (from ATG to tTG at codon
#1), A represents the alternative ATG initiation codon (#85), giving rise to preOGP, S represents the stop codon (#104) and the black square depicts the OGP-coding
sequence (H490–103). (B) H4tTG1 transgene versus endogenous H4 expression. An aliquot of 20 mg RNA from the spleen (S) and muscle (M) of a 17-week-old
transgenic mouse were subjected to northern analysis using as probe either the rabbit b-globin 30-UTR or a murine histone H4 sequence. 28S and 18S, location of the
ribosomal RNA bands; TG, transgenic mRNA; and mH4, endogenous murine H4 mRNA. (C and D) Ubiquitous H4tTG1 transgene expression. Transgene expression
was measured by northern analysis of 20 mg RNA from the indicated tissues of a transgenic (TG) and a wild-type (WT) mouse using the rabbit b-globin 30-UTR as
probe. In (D), the RNA was obtained from either a female or a male as indicated.
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Figure 5. High trabecular bone mass in female H4tTG1 transgenic mice. mCT analysis was performed in the distal femoral metaphysis of 8-, 17- and 34-week-old
female (A–D) and male (E–H) mice. (A and E) Trabecular bone volume density (BV/TV); (B and F) trabecular number (Tb.N); (C and G) trabecular thickness
(Tb.Th); (D and H), trabecular connectivity density (Conn.D). (I–J) Representative 3D mCT images of distal femoral metaphyseal trabecular bone from a 17-week-
old wild-type (I) and transgenic (J) female mice with median BV/TV values. Data are mean–SEM. Shaded squares, H4tTG transgenic; solid squares, wild-type mice;
*P < 0.05.
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problematic. First, molecular targeting of OGP, such as by
gene ablation or RNA interference, would also target histone
H4 expression. Second, gene replacement studies (knock-in)
for histones are unrealistic given their multiple copies in
mammalian genomes (27).
Mammalian histone H4 genes are tightly regulated by both
transcriptional and post-transcriptional mechanisms that cou-
ple histone H4 mRNA levels to DNA synthesis. Thus, the
translation of OGP, an osteogenic and hematopoietic regulator
(8,28–30), from histone H4 mRNA provides a functional link
between cell proliferation and osteogenesis/hematopoiesis.
This linkage may be important to replenish the osteogenic
and blood cell pools during the healing processes that follow
osseous and hematopoietic insults, processes inevitably asso-
ciated with strong proliferative responses and hence robust
histone gene expression. Indeed, OGP has been implicated
in the osteogenic and hematopoietic reaction to bone marrow
ablation as well as massive blood loss (8,31,32). The present
study illustrates that the role of histone H4 alternative trans-
lation in regulating bone mass can be recapitulated in the
absence of injury, raising the possibility that histone H4 altern-
ative translation product(s) can be exploited pharmacologic-
ally. For example, OGP or its analogs may simulate cell
proliferation and bone formation in osteoporotic patients, in
addition to their demonstrated potential to enhance fracture
healing (32–34). The selective effect of OGP on trabecular
bone is not disadvantageous for the potential treatment of
osteoporosis because this osseous compartment is the one
most critically affected in osteoporosis. The stimulation of
hematopoiesis by OGP and OGP derivatives and its thera-
peutic potential has been shown elsewhere (28–30), and clin-
ical trials to evaluate the beneficial hematopoietic activity of
OGP are in progress. Finally, the present study suggests that
the long-term and continuous OGP over-production does not
have any gross adverse effects.
Selective effects on the trabecular, not the cortical, bone
compartment have been observed for other regulators of bone
mass, such as leptin and Wnt ligands (35,36). The increased
sensitivity of trabecular bone may result from the higher turn-
over rate of this osseous compartment, leading to increased
requirement for osteoblastic cell renewal. Remarkably, the
effect of the H4tTG1 transgene was substantially stronger
in females compared with males, although the two genders
expressed the transgene at comparable levels. The gender bias
may be secondary to fundamental differences between male
and female bone mass and bone cell regulation, as suggested
by the present and other studies (37,38). The gender bias may
indicate that OGP targets a bone anabolic mechanism, which
operates in female mice at a suboptimal level; in males, this
mechanism may be saturated and thus insensitive to increased
OGP concentrations.
The histone H4 gene structure, with a suboptimal upstream
translational initiation codon and an optimal, in-frame, down-
stream initiation codon, is shared by most if not all mammalian
and plant cells (17). Evolutionary conservation of the upstream
initiation codon at a suboptimal environment for translational
initiation may result from a need to preserve the T+4C+5N+6
second codon encoding a serine. However, it is not impossible
that a need for H4 LRS has played a role as well. Consistent
with this notion, some ciliate species display the interesting
combination of a second G+4C+5C+6 alanine codon, likely
conferring high fidelity of translational initiation on the first
AUG, along with the absence of the downstream in-frame
AUG codon, which in most other eukaryotes would be
responsible for the alternative translation of OGP (17).
Regardless of the evolutionary mechanisms, the stimulation
Figure 6. Increased trabecular bone formation in female H4tTG1 transgenic
mice. Dynamic histomorphometric analysis, based on fluorescing calcein
labels, in the distal femoral metaphysical trabecular bone of 8- and 17-week-
old female (A–C) and male (D–F) mice. (A and D) mineralizing perimeter
(Min.Peri); (B and E) mineral appositional rate (MAR); (C and F) bone
formation rate (BFR). (G–H) Fluorescent images from calcein-labeled distal
femoral metaphyses of a 17-week-old wild-type (G) and transgenic (H) females
with median BFR values. Data are mean – SEM. Shaded bars, H4tTG1 trans-
genic mice; solid bars, wild-type mice; *P < 0.05.
Table 3. Osteoclast numbera in distal femoral metaphysic of H4tTG1
transgenic mice
Age (weeks) Gender WT H4tTG1
8 F 4.4 – 0.8 3.4 – 0.6
17 2.4 – 0.4 2.4 – 0.5
8 M 3.6 – 0.7 2.4 – 0.4
17 2.0 – 0.8 3.3 – 0.9
aN.Oc/BS (mm2).
Data are mean – SEM. Differences between H4tTG1 and WT mice are not
statistically significant (P > 0.05).
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of bone formation and other potential roles of histone alter-
native translation products add to the growing plethora of
mechanisms of gene multi-functionality, which enable com-
plex organisms to develop and function with a limited selec-
tion of protein-coding genes (1,2).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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